Mexico
· Delayed Price · Currency is MXN Inovio Pharmaceuticals Statistics
Total Valuation
BMV:INO has a market cap or net worth of MXN 1.47 billion. The enterprise value is 353.91 million.
| Market Cap | 1.47B |
| Enterprise Value | 353.91M |
Important Dates
The last earnings date was Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 36.67M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +37.06% |
| Shares Change (QoQ) | +28.74% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 33.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 254.18 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.18 |
| EV / Sales | 63.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.17 |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.63 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.44% and return on invested capital (ROIC) is -77.74%.
| Return on Equity (ROE) | -132.44% |
| Return on Assets (ROA) | -61.21% |
| Return on Invested Capital (ROIC) | -77.74% |
| Return on Capital Employed (ROCE) | -176.77% |
| Revenue Per Employee | 43,181 |
| Profits Per Employee | -14.72M |
| Employee Count | 134 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.69% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -82.69% |
| 50-Day Moving Average | 36.11 |
| 200-Day Moving Average | 79.62 |
| Relative Strength Index (RSI) | 64.74 |
| Average Volume (20 Days) | 9 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 9.95 |
Income Statement
In the last 12 months, BMV:INO had revenue of MXN 5.79 million and -1.97 billion in losses. Loss per share was -63.63.
| Revenue | 5.79M |
| Gross Profit | -1.44B |
| Operating Income | -2.17B |
| Pretax Income | -1.97B |
| Net Income | -1.97B |
| EBITDA | -2.13B |
| EBIT | -2.17B |
| Loss Per Share | -63.63 |
Balance Sheet
The company has 1.40 billion in cash and 230.37 million in debt, giving a net cash position of 1.17 billion.
| Cash & Cash Equivalents | 1.40B |
| Total Debt | 230.37M |
| Net Cash | 1.17B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.05B |
| Book Value Per Share | 28.56 |
| Working Capital | 910.91M |
Cash Flow
In the last 12 months, operating cash flow was -2.09 billion and capital expenditures -10.46 million, giving a free cash flow of -2.10 billion.
| Operating Cash Flow | -2.09B |
| Capital Expenditures | -10.46M |
| Free Cash Flow | -2.10B |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -37,430.19% |
| Pretax Margin | -34,079.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BMV:INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.06% |
| Shareholder Yield | -37.06% |
| Earnings Yield | -134.08% |
| FCF Yield | -142.72% |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333333.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333333 |
Scores
BMV:INO has an Altman Z-Score of -28.64. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.64 |
| Piotroski F-Score | n/a |